Meridian buys Gull at lower price:
This article was originally published in Clinica
Executive Summary
Meridian Diagnostics is to buy Fresenius subsidiary Gull Laboratories for $2.25 a share, down from $3 per share which was discussed when the deal was first announced in July. As a result of the deal, which is worth around $19 million, Gull will become a wholly-owned subsidiary of Cincinnati, Ohio-based Meridian. Meridian lowered its original offer earlier this month, basing its new offer on Gull's second-quarter results. Gull, of Salt Lake City, Utah, manufactures tests for the detection of infectious diseases and autoimmune disorders.